Session Agenda | Lymphoma, Leukemia & Myeloma Congress

4 Days. Dozens of Practice-Changing Insights.

The agenda will include a robust mix of clinically driven talks, engaging debates, and interactive case discussions in the field of hematologic malignancies. Each day will be a deep dive into a particular therapeutic area.

October 14-17, 2025 | New York City

6:30 AM – 7:30 AM

Breakfast
7:30 AM – 7:45 AM

Congress Welcome
- Chair
  - Morton Coleman MD
- Room
  - Metropolitan East
7:45 AM – 9:45 AM

Session I: AML
- Speaker
  - Alexander Perl MD
  - Catherine Lai MD, MPH
  - Gail Roboz MD
  - Justin Kaner MD
- Room
  - Metropolitan East
- 7:45 AM – 8:05 AM
  
  Talk: Updates in FLT3+ AML
- 8:05 AM – 8:25 AM
  
  Talk: Management of APL
- 8:25 AM – 8:45 AM
  
  Talk: Practical Management Strategies for Older AML Patients
- 8:45 AM – 9:25 AM
  
  Real-Time Decisions in AML: Who, When, and How to Target
- 9:25 AM – 9:45 AM
  
  Q&A
9:50 AM – 10:20 AM

Exhibit Hall Break
- Room
  - Metropolitan West
10:20 AM – 12:20 PM

Session II: ALL
- Moderator
  - Gail Roboz MD
- Speaker
  - Alexandra Gomez Arteaga MD
  - Elias Jabbour MD
  - Kristen O'Dwyer MD
  - Wendy Stock MD, MA
- Room
  - Metropolitan East
- 10:20 AM – 10:40 AM
  
  Talk: Novel strategies to reduce chemotherapy exposure in younger patients with ALL
- 10:40 AM – 11:00 AM
  
  Talk: When do we Transplant in ALL?
- 11:00 AM – 11:20 AM
  
  Talk: Therapeutic Strategies for Older Patients with ALL
- 11:20 AM – 12:00 PM
  
  Transforming ALL Treatment: Innovations and Future Directions in CAR T-Cell Therapy
- 12:00 PM – 12:20 PM
  
  Q&A
12:30 PM – 1:30 PM

Lunch Innovation Theater/ Symposium (Non-Accredited) (Sponsored by AbbVie)
- Room
  - Empire West
12:30 PM – 1:30 PM

Lunch Innovation Theater/ Symposium (Non-Accredited) (Sponsored by Servier)
- Room
  - Lenox Ballroom
12:30 PM – 1:30 PM

Lunch Innovation Theater/ Symposium (Non-Accredited) (Sponsored by Bristol Myers Squibb)
- Room
  - Central Park West
1:30 PM – 2:45 PM

Session III: MPN
- Moderator
  - Gail Roboz MD
- Speaker
  - Hagop Kantarjian MD
  - Juliet Barker MBBS
- Room
  - Metropolitan East
- 1:30 PM – 1:45 PM
  
  Best Abstract Award Presentation in Leukemia
- 1:45 PM – 1:55 PM
  
  Award Presentation: Richard Silver Award
- 1:55 PM – 2:25 PM
  
  Award Lecture: CML Research and Treatment in 2025
- 2:25 PM – 2:45 PM
  
  Talk: Which Patients with MPN should be Transplanted? A Transplanter’s Perspective
2:45 PM – 3:45 PM

Session III: Mini Symposium and Q&A
- Moderator
  - Gail Roboz MD
- Speaker
  - Ghaith Abu-Zeinah MD
- Room
  - Metropolitan East
- 2:45 PM – 3:25 PM
  
  Mini Symposium: From Diagnosis to Disease Control: Integrating Next-Generation Therapies into ET and PV Management.
- 3:25 PM – 3:45 PM
  
  Q&A
3:50 PM – 4:20 PM

Exhibit Hall Break
- Room
  - Metropolitan West
4:20 PM – 6:20 PM

Session IV: Challenging Topics in Bone Marrow Failure
- Moderator
  - Gail Roboz MD
- Speaker
  - Amy DeZern MD, MHS
  - Jonathan Canaani MD
  - Pinkal Desai MD
- Room
  - Metropolitan East
- 4:20 PM – 4:40 PM
  
  Talk: CHIP, CCUS, and Other 4-letter Marrow Diseases
- 4:40 PM – 5:00 PM
  
  Talk: Aplastic Anemia 2025
- 5:00 PM – 5:20 PM
  
  Talk: Updates in Low-risk MDS
- 5:20 PM – 5:40 PM
  
  Q&A
- 5:40 PM – 6:20 PM
  
  Case Discussions in Leukemia
6:20 PM – 7:20 PM

Welcome Reception
- Room
  - Metropolitan West
7:00 PM – 8:30 PM

Fellows Reception
- Room
  - Lenox Ballroom

7:00 AM – 7:30 AM

Breakfast
7:30 AM – 7:35 AM

Welcome
- Co-Chair
  - John Leonard MD
- Room
  - Metropolitan East
7:35 AM – 9:35 AM

Session V: Emerging Science in Lymphoma
- Speaker
  - David Russler-Germain MD, PhD
  - Giorgio Inghirami MD
  - John Timmerman MD
  - Lisa Roth MD
- Room
  - Metropolitan East
- 7:35 AM – 7:55 AM
  
  Talk: Patient Derived Xenografts (PDX) in Lymphoma Research
- 7:55 AM – 8:15 AM
  
  Talk: Epstein Barr Virus and Lymphoma – What’s the Connection and Does it Matter?
- 8:15 AM – 8:35 AM
  
  Talk: Where do We Stand with ctDNA and Lymphoma?
- 8:35 AM – 9:15 AM
  
  Vaccine therapy for lymphoma, back to the future?
- 9:15 AM – 9:35 AM
  
  Q&A
9:40 AM – 10:10 AM

Exhibit Hall Break
- Room
  - Metropolitan West
10:10 AM – 11:10 AM

Session VI: Low Grade (Indolent) Lymphoma Scenarios
- Moderator
  - Jia Ruan MD, PhD
- Speaker
  - Alison Moskowitz MD
  - Jonathan Friedberg MD
  - Leo Gordon MD
- Room
  - Metropolitan East
- 10:10 AM – 10:30 AM
  
  Talk: Extranodal Marginal Zone Lymphomas – When to Watch, When to Radiate, When to Treat Systemically?
- 10:30 AM – 10:50 AM
  
  Talk: Key Aspects of Management of Cutaneous Lymphomas
- 10:50 AM – 11:10 AM
  
  Talk: How I Approach the Initial Management of Follicular Lymphoma and can we talk about Cure?
11:10 AM – 12:10 PM

Session VI: Mini Symposium and Q&A
- Moderator
  - Jia Ruan MD, PhD
- Speaker
  - Erin Mulvey MD
  - John Leonard MD
- Room
  - Metropolitan East
- 11:10 AM – 11:50 AM
  
  Mini Symposium: Advances in R/R Follicular Lymphoma: Diagnostic Approaches and Novel Therapeutic Options
- 11:50 AM – 12:10 PM
  
  Q&A
12:15 PM – 1:15 PM

Lunch Innovation Theater/ Symposium (Non-Accredited) (Sponsored by Lilly)
- Room
  - Empire West
12:15 PM – 1:15 PM

Lunch Innovation Theater/ Symposium (Non-Accredited) (Sponsored by Taiho Oncology, Inc)
- Room
  - Central Park West
12:15 PM – 1:15 PM

Lunch Innovation Theater/ Symposium (Non-Accredited) (Sponsored by Pfizer)
- Room
  - Lenox Ballroom
1:15 PM – 2:30 PM

Session VII: Moving Towards More Cures in B Cell Lymphoma
- Moderator
  - John Leonard MD
- Speaker
  - Ari Melnick MD
  - Catherine Diefenbach MD
  - Jeremy Abramson MD, MMSc
- Room
  - Metropolitan East
- 1:15 PM – 1:30 PM
  
  Best Abstract Award Presentation
- 1:30 PM – 1:40 PM
  
  Award Presentation: ARENA Foundation for Medical Research Award: John Ultmann Award for Major Contribution to Lymphoma Research
- 1:40 PM – 2:10 PM
  
  Award Lecture: What does the Future Hold in Science-driven Strategies for B Cell Lymphoma?
- 2:10 PM – 2:30 PM
  
  Debate: Approaches to management of recurrent Diffuse large B cell lymphoma
2:30 PM – 3:30 PM

Session VII: Mini Symposium and Q&A
- Moderator
  - John Leonard MD
- Speaker
  - Stephen Schuster MD
- Room
  - Metropolitan East
- 2:30 PM – 3:10 PM
  
  MiniSymposium: Precision at the Edge: Optimizing CAR T-Cell Therapy for R/R DLBCL
- 3:10 PM – 3:30 PM
  
  Q&A
3:30 PM – 4:00 PM

Exhibit Hall Break
- Room
  - Metropolitan West
4:00 PM – 4:40 PM

Session VIII: T cell and Hodgkin's Lymphoma
- Speaker
  - Astrid Pavlovsky MD
  - Sarah Rutherford MD
- Room
  - Metropolitan East
- 4:00 PM – 4:20 PM
  
  Talk: How I Approach Limited Stage Hodgkin's Lymphoma
- 4:20 PM – 4:40 PM
  
  Talk: How I Approach Older Patients with Hodgkin's Lymphoma
4:40 PM – 6:00 PM

Session VIII: Mini Symposium and Q&A
- Moderator
  - Sarah Rutherford MD
- Speaker
  - Jia Ruan MD, PhD
- Room
  - Metropolitan East
- 4:40 PM – 5:20 PM
  
  Mini Symposium: What’s Next in Peripheral T-Cell Lymphoma: Novel Agents, Evolving Strategies, and Future Pathways
- 5:20 PM – 6:00 PM
  
  Q&A and Case Discussions
6:00 PM – 8:30 PM

Lymphoma Rounds at Lymphoma, Leukemia & Myeloma Congress
- Faculty
- Presenter
  - Adam Kittai MD, MBA
  - David Russler-Germain MD, PhD
  - Graham Wehmeyer

6:30 AM – 7:30 AM

Spanish Session in Lymphoma
- Chair
  - Astrid Pavlovsky MD
- Panelist
  - Ari Melnick MD
  - Jorge Castillo MD
7:00 AM – 7:30 AM

Breakfast
7:30 AM – 7:35 AM

Welcome
- Co-Chair
  - Ruben Niesvizky MD
7:35 AM – 8:35 AM

Session IX: Understanding and Managing Early Disease
- Moderator
  - Ola Landgren MD, PhD
- Speaker
  - Irene Ghobrial MD
  - Mateo Mejia Saldarriaga MD
  - Sagar Lonial MD, FACP, FASCO
- Room
  - Metropolitan East
- 7:35 AM – 7:55 AM
  
  Talk: MGUS and Smoldering Myeloma: When to Watch, When to Act
- 7:55 AM – 8:15 AM
  
  Talk: Biomarkers of Progression: Who Will Evolve to Active Disease?
- 8:15 AM – 8:35 AM
  
  Talk: Risk-Adapted Strategies for High-Risk Smoldering Myeloma
8:35 AM – 9:35 AM

Session IX: Mini Symposium and Q&A
- Moderator
  - Ola Landgren MD, PhD
- Speaker
  - Amrita Krishnan MD FACP
  - Suzanne Lentzsch MD, PhD
- Room
  - Metropolitan East
- 8:35 AM – 9:15 AM
  
  Mini Symposium: Newly Diagnosed Multiple Myeloma: Evolving Strategies for Frontline Treatment to Achieve Deeper and More Durable Responses
- 9:15 AM – 9:35 AM
  
  Q&A
9:40 AM – 10:10 AM

Exhibit Hall Break
- Room
  - Metropolitan West
10:10 AM – 12:10 PM

Session X: New Biology and Treatments
- Moderator
  - Mark Bustoros MD
- Speaker
  - Cristina Gasparetto MD
  - Nikhil Munshi MD
  - Ola Landgren MD, PhD
  - Samir Parekh MD
- Room
  - Metropolitan East
- 10:10 AM – 10:30 AM
  
  Talk: Myeloma Genomics: Real-Time Precision Medicine in the Clinic
- 10:30 AM – 10:50 AM
  
  Talk: Targeting the Bone Marrow Microenvironment
- 10:50 AM – 11:10 AM
  
  Talk: Overcoming Resistance in Heavily Pretreated Patients
- 11:10 AM – 11:30 AM
  
  Talk: Novel Antigens and Next-Gen Targets in Myeloma Immunotherapy
- 11:30 AM – 11:50 AM
  
  Talk: Next-Generation IMiDs and CELMoDs: Game Changers in Relapsed Myeloma
- 11:50 AM – 12:10 PM
  
  Q&A
12:20 PM – 1:20 PM

Lunch Innovation Theater/ Symposium (Non-Accredited) (Sponsored by Regeneron)
- Room
  - Empire West
12:20 PM – 1:20 PM

Lunch Innovation Theater/ Symposium (Non-Accredited) (Sponsored by Johnson & Johnson)
- Room
  - Lenox Ballroom
1:20 PM – 3:35 PM

Session XI: Advancing Treatments in Myeloma
- Moderator
  - Ruben Niesvizky MD
- Speaker
  - Adriana Rossi MD
  - Mateo Mejia Saldarriaga MD
  - Natalie Callander MD
  - Ola Landgren MD, PhD
  - Paul Richardson MD
- Room
  - Metropolitan East
- 1:20 PM – 1:35 PM
  
  Best Abstract Award Presentation
- 1:35 PM – 1:45 PM
  
  Talk: Award Presentation: ARENA Foundation for Medical Research Award: Joseph Michaeli Award for Outstanding Contributions to Myeloma
- 1:45 PM – 2:15 PM
  
  Award Lecture: From Bench to Bedside: The Evolution of Myeloma Therapeutics
- 2:15 PM – 2:35 PM
  
  Talk: Cellular Therapies in Earlier Lines: Are We Ready ?
- 2:35 PM – 2:55 PM
  
  Q&A
- 2:55 PM – 3:35 PM
  
  Case Discussions in Myeloma
3:40 PM – 4:10 PM

Exhibit Hall Break
- Room
  - Metropolitan West
4:10 PM – 5:10 PM

Session XII: Frontiers in Immunotherapy and Future Directions
- Moderator
  - Ruben Niesvizky MD
- Speaker
  - Adriana Rossi MD
  - Joseph Mikhael MD, MEd, FRCPC
  - Noopur Raje MD
- Room
  - Metropolitan East
- 4:10 PM – 4:30 PM
  
  Talk: Bispecific Antibodies: Clinical Updates and Real-World Experience
- 4:30 PM – 4:50 PM
  
  Talk: Bridging CAR T-Cell Therapy and Bispecifics: Sequencing and Safety
- 4:50 PM – 5:10 PM
  
  Talk: Managing Toxicities of T-Cell Directed Therapies
5:10 PM – 6:10 PM

Session XII: Mini Symposium and Q&A
- Moderator
  - Ruben Niesvizky MD
- Speaker
  - Adam Cohen MD
  - Joshua Richter MD, FACP
- Room
  - Metropolitan East
- 5:10 PM – 5:50 PM
  
  Mini Symposium: Evolving Strategies for CAR T-Cell Therapy in Relapsed/Refractory Multiple Myeloma
- 5:50 PM – 6:10 PM
  
  Q&A
6:20 PM – 7:20 PM

Dinner Innovation Theater/ Symposium (Non-Accredited) (Sponsored by Johnson & Johnson)
- Room
  - Lenox Ballroom

6:30 AM – 7:30 AM

Spanish Session in Myeloma
- Chair
  - Ruben Niesvizky MD
- Panelist
  - Mateo Mejia Saldarriaga MD
7:00 AM – 7:30 AM

Breakfast
7:30 AM – 7:35 AM

Welcome
- Co-Chair
  - Richard Furman MD
7:35 AM – 8:35 AM

Session XIII: CLL Therapeutics
- Speaker
  - Alexey Danilov MD, PhD
  - Richard Furman MD
  - Susan O'Brien MD
- Room
  - Metropolitan East
- 7:35 AM – 7:55 AM
  
  Talk: CLL: What is Left to Learn?
- 7:55 AM – 8:15 AM
  
  Talk: Update from iwCLL 2025
- 8:15 AM – 8:35 AM
  
  Debate: Intermittent vs Continous Therapy:
8:35 AM – 9:35 AM

Session XIII: Mini Symposium and Q&A
- Speaker
  - Adam Kittai MD, MBA
  - Richard Furman MD
- Room
  - Metropolitan East
- 8:35 AM – 9:15 AM
  
  Mini Symposium: Novel Targeted Therapeutics and Essential Strategies for Optimized Outcomes in Chronic Lymphocytic Leukemia
- 9:15 AM – 9:35 AM
  
  Q&A
9:40 AM – 10:10 AM

Exhibit Hall Break
- Room
  - Metropolitan West
10:10 AM – 12:10 PM

Session XIV: CLL and Richter's Transformation
- Moderator
  - Richard Furman MD
- Speaker
  - Elisa ten Hacken PhD
  - Erin Mulvey MD
  - John Allan MD
  - Matthew Davids MD, MMSc
- Room
  - Metropolitan East
- 10:10 AM – 10:40 AM
  
  Rai Lecture: Risk Factors for the Development of Richter Transformation
- 10:40 AM – 11:00 AM
  
  Talk: Bispecific Antibodies in CLL and Richter Transformations
- 11:00 AM – 11:30 AM
  
  Prince Family Lecture: Molecular Mechanisms Underlying CLL Transformation
- 11:30 AM – 11:50 AM
  
  Talk: Therapeutic Options for Richter Transformation
- 11:50 AM – 12:10 PM
  
  Q&A
12:20 PM – 1:20 PM

Lunch Innovation Theater/ Symposium (Non-Accredited) (Sponsored by AbbVie)
- Room
  - Empire West
12:20 PM – 1:20 PM

Lunch Innovation Theater/ Symposium (Non-Accredited) (Sponsored by AstraZeneca)
- Room
  - Lenox Ballroom
1:20 PM – 3:20 PM

Session XV: CLL: Future Directions
- Moderator
  - Richard Furman MD
- Speaker
  - Alexey Danilov MD, PhD
  - Jennifer Brown MD, PhD
  - Neil Kay MD
  - Nicole Lamanna MD
  - Stephen Schuster MD
- Room
  - Metropolitan East
- 1:20 PM – 1:40 PM
  
  Talk: Non-covalent BTKi’s: What To Grab On To?
- 1:40 PM – 2:00 PM
  
  Talk: CAR T Cell Therapy in CLL: How to Use The Big Gun?
- 2:00 PM – 2:20 PM
  
  Talk: Autoimmunity in CLL
- 2:20 PM – 2:40 PM
  
  Talk: How to Use MRD to Manage Your CLL Patient
- 2:40 PM – 3:00 PM
  
  What is Next: Degraders in CLL
- 3:00 PM – 3:20 PM
  
  Q&A
3:25 PM – 3:40 PM

Coffee Break
3:40 PM – 5:20 PM

Session XVI: Waldenstrom's Macroglobulinemia and Case Discussions
- Moderator
  - Richard Furman MD
- Speaker
  - Alexey Danilov MD, PhD
  - Jennifer Brown MD, PhD
  - John Allan MD
  - Jorge Castillo MD
  - Neil Kay MD
- 3:40 PM – 3:50 PM
  
  Award Presentation: IWMF Bruce Waterfall Memorai Lecture
- 3:50 PM – 4:20 PM
  
  Award Lecture: How does Biology Impact the Management of Waldenstrom's Macroglobulinemia?
- 4:20 PM – 5:20 PM
  
  Case Discussions

Agenda

Agenda

4 Days. Dozens of Practice-Changing Insights.

October 14-17, 2025 | New York City

Tuesday October 14, 2025

Breakfast

Congress Welcome

Session I: AML

Exhibit Hall Break

Session II: ALL

Lunch Innovation Theater/ Symposium (Non-Accredited) (Sponsored by AbbVie)

Lunch Innovation Theater/ Symposium (Non-Accredited) (Sponsored by Servier)

Lunch Innovation Theater/ Symposium (Non-Accredited) (Sponsored by Bristol Myers Squibb)

Session III: MPN

Session III: Mini Symposium and Q&A

Exhibit Hall Break

Session IV: Challenging Topics in Bone Marrow Failure

Welcome Reception

Fellows Reception

Wednesday October 15, 2025

Breakfast

Welcome

Session V: Emerging Science in Lymphoma

Exhibit Hall Break

Session VI: Low Grade (Indolent) Lymphoma Scenarios

Session VI: Mini Symposium and Q&A

Lunch Innovation Theater/ Symposium (Non-Accredited) (Sponsored by Lilly)

Lunch Innovation Theater/ Symposium (Non-Accredited) (Sponsored by Taiho Oncology, Inc)

Lunch Innovation Theater/ Symposium (Non-Accredited) (Sponsored by Pfizer)

Session VII: Moving Towards More Cures in B Cell Lymphoma

Session VII: Mini Symposium and Q&A

Exhibit Hall Break

Session VIII: T cell and Hodgkin's Lymphoma

Session VIII: Mini Symposium and Q&A

Lymphoma Rounds at Lymphoma, Leukemia & Myeloma Congress

Thursday October 16, 2025

Spanish Session in Lymphoma

Breakfast

Welcome

Session IX: Understanding and Managing Early Disease

Session IX: Mini Symposium and Q&A

Exhibit Hall Break

Session X: New Biology and Treatments

Lunch Innovation Theater/ Symposium (Non-Accredited) (Sponsored by Regeneron)

Lunch Innovation Theater/ Symposium (Non-Accredited) (Sponsored by Johnson & Johnson)

Session XI: Advancing Treatments in Myeloma

Exhibit Hall Break

Session XII: Frontiers in Immunotherapy and Future Directions

Session XII: Mini Symposium and Q&A

Dinner Innovation Theater/ Symposium (Non-Accredited) (Sponsored by Johnson & Johnson)

Friday October 17, 2025

Spanish Session in Myeloma

Breakfast

Welcome

Session XIII: CLL Therapeutics

Session XIII: Mini Symposium and Q&A

Exhibit Hall Break

Session XIV: CLL and Richter's Transformation

Lunch Innovation Theater/ Symposium (Non-Accredited) (Sponsored by AbbVie)

Lunch Innovation Theater/ Symposium (Non-Accredited) (Sponsored by AstraZeneca)

Session XV: CLL: Future Directions

Coffee Break

Session XVI: Waldenstrom's Macroglobulinemia and Case Discussions